TG Therapeutics, Inc. (TGTX) Posts Q4 Loss of 19c/Share
TG Therapeutics, Inc. (NASDAQ: TGTX) reported Q4 EPS of ($0.19) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
